Application of 3, 5-dinitrophenyl-pyrazolo [3, 4-d] [1,3] oxazine as tumor drug resistance reversal agent

A technology of dinitrophenyl and drug resistance reversal, which is applied in the field of medical technology, can solve problems such as reducing the antitumor effect of drugs, and achieve good guiding significance.

Active Publication Date: 2021-02-26
无锡享源信息科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

ABCG2 transporter can pump anti-tumor drugs such as mitoxantrone, gefitinib, doxorubicin and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 3, 5-dinitrophenyl-pyrazolo [3, 4-d] [1,3] oxazine as tumor drug resistance reversal agent
  • Application of 3, 5-dinitrophenyl-pyrazolo [3, 4-d] [1,3] oxazine as tumor drug resistance reversal agent
  • Application of 3, 5-dinitrophenyl-pyrazolo [3, 4-d] [1,3] oxazine as tumor drug resistance reversal agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] The drug resistance reversal experiment of the compound of embodiment 1 to tumor cells

[0041] 1. Drug-resistant cell culture: S1-MI-80 cells are a MX-induced ABCG2 overexpression-resistant subline derived from the human colon cancer cell line S123. S1-MI-80 was cultured in DMEM medium. All cell lines were maintained at 37°C in 5% CO 2 in a humid incubator.

[0042] 2. Cytotoxicity testing: MTT colorimetric cell proliferation assay was used to determine drug sensitivity in in vitro cell models. Prepare a single-cell suspension and seed it on a 96-well plate at 160 μL per well in CO 2 After culturing in the incubator for 24 hours, add a series of concentrations (0, 1, 2, 4, 8, 18, 32 μmol / L) of 1-phenyl-6-(3,5-dinitrophenyl)-pyrazolo [3,4-d][1,3]oxazin-4(1H)-one. Add 20 μL of 0.5% MTT to each well and incubate for an additional 4 hours. The supernatant was then removed, and 150 μL of DMSO was added to each well to dissolve MTT crystals. The absorbance was detecte...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicines, and relates to an application of 3, 5-dinitrophenyl-pyrazolo [3, 4-d] [1,3] oxazine as a tumor drug resistance reversal agent. Researches show that 1-phenyl-6-(3, 5-dinitrophenyl)-pyrazolo[3, 4-d] [1, 3] oxazine-4(1H)-ketone can significantly improve the sensitivity of tumor cells to antitumor drugs and reverse the drug resistance of the tumor cells, and the treatment dosage is safe and non-toxic, so that the compound has potential to become a novel tumor drug resistance reversal agent. Based on the research results, the compound can be used for adjuvant therapy of a chemotherapy regimen and can be matched with other anti-tumor drugs for common medication, and has good clinical medication significance.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to 3,5-dinitrophenyl-pyrazolo[3,4-d][1,3]oxazine compounds——1-phenyl-6-(3, The application of 5-dinitrophenyl)-pyrazolo[3,4-d][1,3]oxazin-4(1H)-one as tumor resistance reversal agent, and including 1-phenyl-6 Application of a pharmaceutical composition of -(3,5-dinitrophenyl)-pyrazolo[3,4-d][1,3]oxazin-4(1H)-one in the preparation of antitumor agents. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Tumor multidrug resistance (multidrug resistance, MDR) has always been a worldwide problem that plagues cancer treatment. MDR refers to the long-term exposure of tumor cel...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/5365A61P35/00A61P35/02A61K31/136A61K31/704
CPCA61K31/136A61K31/5365A61K31/704A61P35/00A61P35/02A61K2300/00
Inventor 类红旭盛卸晃赵子婧郝梦珠卢佳澳
Owner 无锡享源信息科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap